Recombinant Human Basic Fibroblast Growth Factor

Recombinant Human Basic Fibroblast Growth Factor

Uses

Investigated for use/treatment in coronary artery disease, peripheral vascular disease, periodontal disease, bone fractures, entero-related fistulae, and diabetic foot ulcers.

How Recombinant Human Basic Fibroblast Growth Factor works

Recombinant Human Basic Fibroblast Growth Factor, or basic fibroblast growth factor 2 (bFGF) is a recombinant human growth factor used to stimulate angiogenesis and keratinization in wound healing. It stimulates migration of monocytes, neutrophils, macrophages, fibroblasts and also assists in creation of granulation tissue (the tissue that replaces fibrin clots in healing wounds).

Recombinant Human Basic Fibroblast Growth Factor

Trade Name	Recombinant Human Basic Fibroblast Growth Factor
Generic	Trafermin
Trafermin Other Names	Recombinant human basic fibroblast growth factor, rhbFGF, Trafermin
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	August 5, 2021 at 12:40 pm

Structure

Table Of contents

• Recombinant Human Basic Fibroblast Growth Factor
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Innovators Monograph

You find simplified version here Recombinant Human Basic Fibroblast Growth Factor